Wen-Tsan Chang Selected Research

Wen-Tsan Chang Research Topics

Disease

41	Neoplasms (Cancer) 05/2024 - 04/2008
24	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 10/2004
9	Neoplasm Metastasis (Metastasis) 03/2023 - 03/2004
8	Infections 10/2021 - 05/2002
6	Lung Neoplasms (Lung Cancer) 06/2017 - 12/2010
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2023 - 01/2014
4	Disease Progression 04/2024 - 07/2018
4	Inflammation (Inflammations) 01/2023 - 06/2011
4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2012
3	Liver Neoplasms (Liver Cancer) 04/2024 - 01/2017
3	Fibrosis (Cirrhosis) 02/2023 - 04/2005
3	Carcinogenesis 01/2021 - 01/2012
3	Liver Cirrhosis (Hepatic Cirrhosis) 03/2013 - 09/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2023 - 01/2017
2	Dyslipidemias (Dyslipidemia) 02/2023 - 01/2017
2	Wound Infection (Wound Infections) 11/2022 - 08/2004
2	Fistula 05/2022 - 01/2012
2	Sepsis (Septicemia) 05/2022 - 10/2021
2	Necrosis 08/2020 - 06/2011
2	Breast Neoplasms (Breast Cancer) 09/2019 - 01/2017
2	Lewis Lung Carcinoma 01/2018 - 01/2017
2	Diabetic Nephropathies (Diabetic Nephropathy) 10/2016 - 01/2012
2	Chronic Hepatitis C 12/2015 - 11/2008
2	Insulin Resistance 08/2013 - 01/2012
2	Adenocarcinoma of Lung 01/2013 - 12/2010
2	Obesity 06/2011 - 02/2006
2	Chronic Hepatitis B 04/2005 - 10/2004
1	Pain (Aches) 01/2024
1	Postoperative Pain 01/2024
1	Autosomal Recessive 59 Deafness 05/2023
1	Rupture 05/2023
1	Autosomal Dominant 5 Deafness 05/2023
1	Adenocarcinoma 03/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 02/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023
1	Hyperamylasemia 11/2022
1	Lacerations 05/2022
1	Liver Abscess 05/2022

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 08/2023 - 03/2008
6	Fibronectins (Fibronectin)IBA 09/2022 - 01/2017
5	Biomarkers (Surrogate Marker)IBA 03/2023 - 01/2019
5	CeramidesIBA 05/2022 - 04/2008
4	Sorafenib (BAY 43-9006)FDA Link 04/2024 - 07/2018
4	EnzymesIBA 04/2018 - 01/2012
4	Small Interfering RNA (siRNA)IBA 01/2018 - 09/2008
3	N-acetylsphingosineIBA 03/2021 - 01/2014
3	Messenger RNA (mRNA)IBA 09/2019 - 11/2004
3	Epirubicin (Ellence)FDA LinkGeneric 01/2018 - 01/2014
3	Interleukin-6 (Interleukin 6)IBA 10/2016 - 12/2010
3	eugenosedin-AIBA 03/2014 - 06/2011
3	Surface Antigens (Surface Antigen)IBA 06/2010 - 10/2004
3	Anti-Bacterial Agents (Antibiotics)IBA 06/2006 - 05/2002
2	Fatty Acid DesaturasesIBA 02/2023 - 01/2017
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2023 - 01/2017
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
2	Long Noncoding RNAIBA 01/2023 - 01/2021
2	regorafenibIBA 07/2022 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2020 - 01/2017
2	micaIBA 10/2018 - 12/2015
2	pterostilbeneIBA 01/2018 - 01/2017
2	AnthracyclinesIBA 01/2018 - 05/2014
2	CamptothecinIBA 06/2017 - 01/2016
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 06/2017 - 01/2016
2	Arecoline (Arecolin)IBA 01/2017 - 01/2012
2	LipidsIBA 01/2017 - 04/2008
2	AlbuminsIBA 10/2016 - 09/2008
2	CreatinineIBA 10/2016 - 11/2012
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 08/2015 - 11/2012
2	Progesterone FDA LinkGeneric 05/2014 - 01/2014
2	LeptinIBA 08/2013 - 02/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013 - 01/2013
2	Serum AlbuminIBA 11/2012 - 08/2004
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2012 - 12/2010
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2011 - 11/2003
2	LipopolysaccharidesIBA 01/2006 - 11/2005
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2005 - 10/2004
2	Membrane Proteins (Integral Membrane Proteins)IBA 04/2005 - 11/2004
1	Nalbuphine (Nubain)FDA LinkGeneric 01/2024
1	Opioid Analgesics (Opioids)IBA 01/2024
1	fluoreneIBA 09/2023
1	Antineoplastic Agents (Antineoplastics)IBA 08/2023
1	CytokinesIBA 05/2023
1	GasderminsIBA 05/2023
1	imidazoleacetic acid (IMAC)IBA 02/2023
1	Lipoproteins (Lipoprotein)IBA 02/2023
1	Ribonuclease P (RNase P)IBA 01/2023
1	Transfer RNA (tRNA)IBA 01/2023
1	mangostinIBA 09/2022
1	SphingolipidsIBA 05/2022
1	perfluoro- 2,2,2',2'- tetramethyl- 4,4'- bis(1,3- dioxolane)IBA 05/2022

Therapy/Procedure

11	Therapeutics 08/2023 - 12/2015
6	Drug Therapy (Chemotherapy) 04/2024 - 04/2008
3	Liver Transplantation 10/2021 - 01/2012
2	Laparoscopic Cholecystectomy 01/2024 - 06/2006
2	Splenectomy 01/2013 - 11/2008
1	Immunotherapy 05/2024
1	Immunomodulation 03/2023
1	Hepatectomy 02/2023
1	Conservative Treatment 11/2022
1	Transplantation 05/2022